JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
PUT
CME Group
CME
$95.9B
| $14.2M | ﹤0.01% |
61,000
-85,000
| -58% | -$19.5M |
2017 Q4
28 quarters
|
|
2327
PUT
Dell
DELL
$354B
| $14.2M | ﹤0.01% |
122,900
+83,400
| +211% | +$10.5M |
2023 Q1
7 quarters
|
|
2328
PUT
Abbott
ABT
$173B
| $14.2M | ﹤0.01% |
125,200
-27,400
| -18% | -$3.17M |
2017 Q3
29 quarters
|
|
2329
PAR Technology
PAR
$616M
| $14.2M | ﹤0.01% |
194,764
+136,291
| +233% | +$9.32M |
2018 Q2
26 quarters
|
|
2330
Tandem Diabetes Care
TNDM
$1.16B
| $14.1M | ﹤0.01% |
392,586
+195,003
| +99% | +$6.6M |
2018 Q1
27 quarters
|
|
2331
PUT
Bristol-Myers Squibb
BMY
$120B
| $14.1M | ﹤0.01% |
249,400
| – | – |
2014 Q2
42 quarters
|
|
2332
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.18B
| $14.1M | ﹤0.01% |
72,802
+584
| +0.8% | +$115K |
2015 Q4
36 quarters
|
|
2333
Valvoline
VVV
$3.84B
| $14.1M | ﹤0.01% |
389,186
-161,710
| -29% | -$6.47M |
2016 Q3
33 quarters
|
|
2334
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.08B
| $14.1M | ﹤0.01% |
325,212
+91,129
| +39% | +$4.13M |
2019 Q4
20 quarters
|
|
2335
CALL
Lamb Weston
LW
$5.93B
| $14M | ﹤0.01% |
210,000
+150,000
| +250% | +$11.2M |
2023 Q3
5 quarters
|
|
2336
Assured Guaranty
AGO
$3.03B
| $14M | ﹤0.01% |
155,526
+14,565
| +10% | +$1.27M |
2013 Q2
46 quarters
|
|
2337
California Water Service
CWT
$2.82B
| $14M | ﹤0.01% |
308,704
+147,043
| +91% | +$7.42M |
2013 Q2
46 quarters
|
|
2338
Otter Tail
OTTR
$3.74B
| $14M | ﹤0.01% |
189,345
+91,516
| +94% | +$7.17M |
2016 Q4
32 quarters
|
|
2339
Invesco DB Agriculture Fund
DBA
$1.23B
| $14M | ﹤0.01% |
525,315
-139,082
| -21% | -$3.63M |
2020 Q3
17 quarters
|
|
|
QXO
2340
QXO Inc
QXO
$12.4B
| $14M | ﹤0.01% |
877,902
+737,192
| +524% | +$11.6M |
2024 Q3
1 quarter
|
|
2341
New Mountain Finance
NMFC
$653M
| $14M | ﹤0.01% |
1,238,952
-19,890
| -2% | -$229K |
2015 Q4
36 quarters
|
|
2342
PUT
Wayfair
W
$14.3B
| $13.9M | ﹤0.01% |
314,200
+19,800
| +7% | +$934K |
2020 Q3
17 quarters
|
|
2343
Adient
ADNT
$1.35B
| $13.8M | ﹤0.01% |
802,540
+394,111
| +96% | +$7.88M |
2022 Q1
11 quarters
|
|
2344
Applied Finance Valuation Large Cap ETF
VSLU
$571M
| $13.8M | ﹤0.01% |
377,665
+23,971
| +7% | +$883K |
2023 Q3
5 quarters
|
|
2345
Kinetik
KNTK
$4.31B
| $13.8M | ﹤0.01% |
243,236
+85,378
| +54% | +$4.62M |
2019 Q1
23 quarters
|
|
|
CRNX
2346
DELISTED
Crinetics Pharmaceuticals
CRNX
| $13.8M | ﹤0.01% |
269,543
-16,413
| -6% | -$918K |
2018 Q3
25 quarters
|
|
2347
Shift4
FOUR
$2.97B
| $13.8M | ﹤0.01% |
132,689
+82,747
| +166% | +$8.21M |
2020 Q3
17 quarters
|
|
2348
PUT
Sysco
SYY
$36.6B
| $13.8M | ﹤0.01% |
+180,000
| New | +$13.8M |
2024 Q4
0 quarters
|
|
2349
MGE Energy Inc
MGEE
$2.68B
| $13.7M | ﹤0.01% |
146,008
+86,423
| +145% | +$8.35M |
2013 Q2
46 quarters
|
|
2350
RXO
RXO
$4.69B
| $13.7M | ﹤0.01% |
575,286
+303,224
| +111% | +$8.46M |
2022 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.